SLU Study: Immune Dysfunction Increases Cancer Risk in Obese Populations
11/14/2024
ST. LOUIS —Researchers at Saint Louis University’s School of Medicine say T-cell dysfunction is leading to an increased risk of cancer in obese populations.
T cells are white blood cells called lymphocytes essential to your immune system in the fight against infections and cancer. Ryan Teague, Ph.D., professor of molecular microbiology and immunology at SLU, and his team are exploring why obesity impacts T-cell dysfunction and compromises immune surveillance, or the body’s ability to survey malignant cells and clear them before they become tumors.
Ryan Teague, Ph.D., left, and Alex Piening, an M.D./Ph.D. graduate student at SLU, work in the lab in Doisy Research Center on October 21, 2024. Photo by Sarah Conroy.
The study, which was led by Teague and co-authored by Alex Piening, an M.D./Ph.D. graduate student at SLU, was recently published in Nature Communications, found that T-cell dysfunction linked to obesity prevented T cells from detecting tumor cells, placing obese mice at higher risk of developing tumors when exposed to a carcinogen. Teague and his team are now trying to uncover the exact mechanism underlying the metabolic dysfunctions associated with obesity that directly impact T-cell function.
Ongoing projects in Teague’s lab at SLU are designed to identify barriers to successful cancer immunotherapy and develop strategies to overcome these barriers for improved patient outcomes. Teague and his team investigate how obesity impacts the efficacy of immunotherapies.
"Immunotherapy boosts a patient's immune system by targeting T cells and reinvigorating them. Paradoxically, immunotherapy is often more successful in patients with obesity, where the immune system isn’t functioning quite as well," Teague said. "Our research explains this paradox by showing that in the setting of obesity, developing tumors are only required to escape a weakened immune system. Such outgrown tumors are not well adapted to evade the reinvigorated T cells elicited during immunotherapy, and thus, are more easily destroyed."
Teague said single-cell RNA sequencing played a critical role in the study’s findings, which allowed scientists to learn what’s happening inside individual immune cells within tumors.
"We learned that the dysfunction in these T cells lies in their inability to kill tumors. Those genes were not being turned on. It also lies in their inability to acquire the metabolic functions needed to sustain anti-tumor activity," Teague said.
Thanks to SLU’s investment in single-cell RNA sequencing technology, the Department of Molecular Microbiology and Immunology has leveraged this new approach to advance its work studying cancer and the immune system, bringing us closer to new cures.
Other authors include Kelly D. Pyles, Kyle S. McCommis, Ph.D., Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine; Emily Ebert, Carter Gottlieb, Niloufar Khojandi, Lindsey M. Kuehm, Stella G. Hoft, Richard J. DiPaolo, Ph.D., Stephen T. Ferris, Ph.D., Elise Alspach, Ph.D., Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine.
Latest Newslink
- SLU History Professor Receives Fulbright Specialist Award to Create Digital Tool Focusing on Gaelic IrelandThomas Finan, Ph.D., associate professor of history at Saint Louis University, has received a Fulbright Specialist Award. He will work with colleagues at the University of Galway to create a joint database of archaeological and historical research focusing on Gaelic Ireland.
- Don't Let that Cookie Crumble: SSE Teams Build, Test Gingerbread HousesTeams of students, faculty and staff in Saint Louis University's School of Science and Engineering recently put their engineering skills to work for a December Innovation Challenge. The teams built gingerbread houses designed to stand up during a weight-loading competition.
- Dr. Edward J. Feser Named 34th President of Saint Louis UniversityFeser, a Roman Catholic, Jesuit-educated leader in higher education, will assume the SLU presidency on July 1, 2025. Feser currently serves as the provost and executive vice president of Oregon State University (OSU), a land-grant institution with more than 38,000 students, a $1.8 billion budget and $480 million annually in externally funded research.
- SLU's Newest Alums Cheered at Commencement CeremonySaturday morning, hundreds of students walked across the stage at Chaifetz Arena and joined the Billiken alumni family. Saint Louis University celebrated its Midyear Commencement on Saturday, Dec. 14, In front of a packed crowd of family members, friends, and loved ones. Those in attendance and watching at home saw the newest graduates of SLU celebrated.
- Amy E. Wright Receives Honorable Mention for MLA's Katherine Singer Kovacs PrizeSaint Louis University's Amy E. Wright, Ph.D., received an honorable mention from the Modern Language Association of America (MLA) for the Katherine Singer Kovacs Prize for an outstanding book published in English or Spanish in the field of Latin American and Spanish literature and cultures. Wright, a professor of Hispanic Studies at SLU, received the honor for her book Serial Mexico: Storytelling across Media, from Nationhood to Now, published in 2023 by Vanderbilt University Press.
- SLU Professor and Author Jonathan Sawday Wins MLA's Prestigious James Russell Lowell PrizeSaint Louis University's Jonathan Sawday, Ph.D., has received the James Russell Lowell Prize for the most outstanding book published in 2023.
